Marjorie C. L. C. Freire

Understanding Drug Release Data through Thermodynamic Analysis

Marjorie C. L. C. Freire, Francisco Alexandrino-Júnior, Henrique Rodrigues Marcelino et al. · Materials · 2017 · 70 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses

Marjorie C. L. C. Freire, Laércio Pol Fachin, Danilo F. Coêlho et al. · ACS Omega · 2017 · 51 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors

Marjorie C. L. C. Freire, G.D. Noske, Natália Vitória Bitencourt et al. · Molecules · 2021 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Functional Wound Dressing as a Potential Treatment for Cutaneous Leishmaniasis

Francisco Alexandrino-Júnior, Kattya Gyselle de Holanda e Silva, Marjorie C. L. C. Freire et al. · Pharmaceutics · 2019 · 26 citations · Full text

Pharmacy, Dermatology, Infectious Diseases +17

Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate

Marjorie C. L. C. Freire, Luis G.M. Basso, Luís F.S. Mendes et al. · Scientific Reports · 2022 · 23 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17